Charles Schwab Investment Management Inc Ventyx Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 488,717 shares of VTYX stock, worth $552,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares

488,717

Previous 485,101 0.75%

Holding current value

$552,250

Previous $1.06 Million 1.23%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$1.72 - $3.12 $6,219 - $11,281	3,616 Added 0.75%	488,717 $1.07 Million
Q3 2024 Nov 12, 2024	BUY	$1.85 - $3.2 $33,111 - $57,273	17,898 Added 3.83%	485,101 $1.06 Million
Q2 2024 Aug 12, 2024	BUY	$2.31 - $5.59 $190,159 - $460,168	82,320 Added 21.39%	467,203 $1.08 Million
Q1 2024 May 08, 2024	BUY	$1.9 - $10.13 $117,216 - $624,950	61,693 Added 19.09%	384,883 $2.12 Million
Q4 2023 Feb 06, 2024	SELL	$2.08 - $31.18 $83,605 - $1.25 Million	-40,195 Reduced 11.06%	323,190 $798,000
Q3 2023 Nov 08, 2023	BUY	$29.8 - $40.3 $3.22 Million - $4.35 Million	107,997 Added 42.29%	363,385 $12.6 Million
Q2 2023 Aug 09, 2023	BUY	$28.53 - $39.55 $1.6 Million - $2.22 Million	56,121 Added 28.16%	255,388 $8.38 Million
Q1 2023 May 11, 2023	SELL	$29.51 - $46.65 $14,932 - $23,604	-506 Reduced 0.25%	199,267 $6.68 Million
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $949,753 - $1.43 Million	39,311 Added 24.5%	199,773 $6.55 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $795,056 - $2.43 Million	62,900 Added 64.47%	160,462 $5.6 Million
Q2 2022 Aug 15, 2022	BUY	$11.95 - $18.75 $283,920 - $445,481	23,759 Added 32.19%	97,562 $1.19 Million
Q1 2022 May 13, 2022	BUY	$10.0 - $19.98 $24,820 - $49,590	2,482 Added 3.48%	73,803 $1 Million
Q4 2021 Feb 11, 2022	BUY	$14.2 - $23.07 $1.01 Million - $1.65 Million	71,321 New	71,321 $1.42 Million

Others Institutions Holding VTYX

# of Institutions

132

Shares Held

55.2M

Call Options Held

81.4K

Put Options Held

148K

View Full List

About Ventyx Biosciences, Inc.

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $63.9M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

More about VTYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ventyx Biosciences, Inc. Transaction History